35 044 0911 EN 1

MCL 30

MCL 30 Dermablate

Fractional Er:YAG (with MICROSPOT EXTENSION SET)

35 044 0911 EN

The third generation of the Dermablate series

MCL 29 Dermablate Dermablate D1 MCL 30 Dermablate

MCL29, the first Er:YAG laser for Dermatology, was introduced in 1996.

35 044 0911 EN

Specifications

Wavelength: 2,940 nm

Power: max. 12 W; voltage 230; 100; 120 V

Puls energy: max. 1.5 J

Fluence: 2 – 10 J/cm² (Ablation, limited)

2 – 100 J/cm² (Ablation, without fluence filter)

1 J/cm² in thermal mode

2 – 162 J/cm² (MicroSpot)

Frequency: 1 / 4 / 8 / 10 / 15 Hz in ablation mode

20 Hz in thermal mode

Spot size: 1 – 6 mm with VarioTEAM handpiece

(Ablation, thermal mode)

13x13 mm with MicroSpot handpiece

(Fractional, 169 MicroSpots with Ø 250 µm and 5% cover rate)

Laser class: 4

35 044 0911 EN

Evidence of clinical success

• 1990: First clinical trials by R. Kaufmann et al.

• 1996: First Er:YAG Laser in dermatology introduced by Asclepion

MCL 29 Dermablate by Asclepion-Meditec, more than 800 systems worldwide

• Germany: the Dermablate has became a standard tool for dermatologists in the treatment of a wide range of cutaneous lesions

• advantages of the Erbium laser compared to CO2 lasers:

- precise and safe ablation

- very limited thermal damage (necrotic zone 30µm/70µm)

- superficial treatments possible as well as deep ablation

- reduced risk of scarring and pigmentation changes

- many treatments require no anaesthesia

- short healing process, little side effects

35 044 0911 EN

• Integrated suction system

• VarioTEAM handpiece

• Subablative mode (coagulation mode)

• Adjustable internal filter system

• Sterilizable distance holder

• Most homogenious beam profile

• Thermal mode

• Unbeaten reliability

• Fast amortisation

• Ugradeable with super fractional extension set (SFE)

USPs

35 044 0911 EN

1 filter - set contains:

• 1 HEPA filter • 1 active coal – filter • 3 pre-filter

sufficiant for 30 hours active use

Integrated filter system

35 044 0911 EN

VarioTEAM handpiece (Ablation)

with TEAM-Technology

(Total Evacuation of Ablated Material)

Very effective smoke evacuation

Lowest smell nuisance

No assistance necessary

Cost reduction

Patents: US 6 162 218 DE 197 106 76

with VarioSpot-Technology

Spot size from 1 to 6 mm

(adjustable in 1mm steps)

Automatic spot size detection

Automatic fluence adaption

VarioTEAM handpiece

35 044 0911 EN

linear correlation

constant ablation depth of 5 µm per 1 J/cm² (above ablation treshhold)

Thermal Mode

Specs: 1 J/cm², 20 Hz, N = 5 ...

coagulation zone up to 400 µm depth (with single impulse up to 40 µm)

Ab

latio

n in

µm

Ablation vs. Fluence

- Different Mechanism of Er:YAG -

Koagulation

Fluence in J/cm2

Ablation

Ablation vs. Coagulation

Recommended parameters 5 – 6 J/cm² conservative 7 – 8 J/cm² normal 9 – 10 J/cm² aggressive treatment

35 044 0911 EN

FLUENCE directly adjustable:

Easy to use

No difficult calculation between energy and spot size

Flat-Top-Profile: most homogenious spot ablation fractional

Other Advantages

35 044 0911 EN

Other Advantages

Modern design + Easy handling + Mobility

35 044 0911 EN

0.0001

0.001

0.01

0.1

1

10

100

1000

10000

100000

100 1000 10000

Wavelength [nm]

Abs

orpt

ion

Coe

ffici

ent [

cm-1

]

400030002000 5000500400300200

Melanin

Protein Water

Scattering

Desoxy-Hemoglobin

Oxy-Hemoglobin

Laser – Selective absorption

High absorbtion in water

Low absorbtion in melanin and hemoglobine

Selective thermolysis (effective targeting and low side effects)

35 044 0911 EN

• Removal of dermal and epidermal lesions:

epidermal naevi, seborrhoic ceratoses, warts, naevuscellnaevus, hypertrophic scars, acne scars, xanthelasma, rhynophym, wrinkles, lentigines, actinic keratoses, syringoma

• full skin resurfacing

• soft laser peel

• skin refreshing

• New fractional laser therapy

By soft and precise ablation.

Indications

35 044 0911 EN

Epidermal naevus

By courtesy of Dr. R. Hartmann, Blaustein, Germany

35 044 0911 EN

Xanthelasma

By courtesy of Dr. R. Hartmann, Blaustein, Germany

35 044 0911 EN

Lentigo senilis

By courtesy of Prof. Dr. E. Haneke, Wuppertal, Germany

35 044 0911 EN

Skin resurfacing

By courtesy of Dres. Hadravek and Salsicky, Plzen, CZ

35 044 0911 EN

Full skin resurfacing

By courtesy of D. Fleming, M.D., Brisbane, Australia

35 044 0911 EN

Full skin resurfacing

By courtesy of D. Fleming, M.D., Brisbane, Australia

35 044 0911 EN

Perioral ablation

By courtesy of D. Fleming, M.D., Brisbane, Australia

35 044 0911 EN

Freckles

By courtesy of D. Fleming, M.D., Brisbane, Australia

35 044 0911 EN

Seborrhoic ceratoses

3 weeks after treatment

By courtesy of Dr. Paul Wood, Proderma, Bad Homburg, Germany

35 044 0911 EN

Dermal / epidermal Naevus

6 months after treatment

By courtesy of Dr. Paul Wood, Proderma, Bad Homburg, Germany

35 044 0911 EN

Verruca seborrhoica pigmentosa

6 months after treatment

By courtesy of Dr. W. Petrow, Bonn, Germany

35 044 0911 EN

Verruca seborrhoica pigmentosa

6 months after treatment

By courtesy of Dr. W. Petrow, Bonn, Germany

35 044 0911 EN

Dermal NCN

6 months after treatment

By courtesy of Dr. W. Petrow, Bonn, Germany

35 044 0911 EN

Milia

By courtesy of Dr. M. Fuchs, Dr. Samimi-Fard, Germany

35 044 0911 EN

Syringoma

By courtesy of Dr. M. Fuchs, Dr. Samimi-Fard, Germany

35 044 0911 EN

35 044 0911 EN

MicroSpot Superfractional Extension Set

35 044 0911 EN

MicroSpot Superfractional Extension Set

35 044 0911 EN

MicroSpot Superfractional Extension Set

35 044 0911 EN

MicroSpot Superfractional Extension Set

35 044 0911 EN

MicroSpot Superfractional Extension Set

35 044 0911 EN

• involvement of the whole epidermis in the healing process • Formation of heat shock proteins deep in the dermis • Resulting in neocollagenesis

MicroSpot Superfractional Extension Set

35 044 0911 EN

MicroSpot Superfractional Extension Set

35 044 0911 EN

MicroSpot Superfractional Extension Set

35 044 0911 EN

MicroSpot Superfractional Extension Set

35 044 0911 EN

MicroSpot Superfractional Extension Set

35 044 0911 EN

MicroSpot Superfractional Extension Set

35 044 0911 EN

MicroSpot Superfractional Extension Set

35 044 0911 EN

MicroSpot Superfractional Extension Set

35 044 0911 EN

MicroSpot Superfractional Extension Set

35 044 0911 EN

MicroSpot Superfractional Extension Set

35 044 0911 EN

MicroSpot Superfractional Extension Set

35 044 0911 EN

MicroSpot Superfractional Extension Set

35 044 0911 EN

MicroSpot Superfractional Extension Set

35 044 0911 EN

MicroSpot Superfractional Extension Set

35 044 0911 EN

MicroSpot Superfractional Extension Set

35 044 0911 EN

MicroSpot Superfractional Extension Set

35 044 0911 EN

MicroSpot Superfractional Extension Set

35 044 0911 EN

MicroSpot Superfractional Extension Set

35 044 0911 EN

• new designed and patented handpiece

• automatic suction and lens cleaning

• cooling outlets integrated in distance holders

• maintenance free

• Microlens technology with 169 fractional spots per shot

• Up to 20 Hz (quickest fractional technology available)

MicroSpot Superfractional Extension Set

35 044 0911 EN

MicroSpot Superfractional Extension Set

Parameter:

Handpiece 13×13mm

Fluence 54 – 72 J/cm²

Micro Pulse 3 – 4

Pass 1 – 3

immediately after

one day after

two days after

three days after

By courtesy of Dr. Daniel, Cassuto, Milano, Italy

35 044 0911 EN

2 treatment within 4 weeks, each treatment with 2 passes, 10 J/cm2, cover rate 15% and 4 shots on the same fractional spots, 2 months

MicroSpot Superfractional Extension Set

By courtesy of Dr. Daniel, Cassuto, Milano, Italy

35 044 0911 EN

2 treatment within weeks, each treatment with 2 passes, 10 J/cm2, cover rate 10% and 4 shots on the same fractional spots, 2 months

MicroSpot Superfractional Extension Set

By courtesy of Dr. Daniel, Cassuto, Milano, Italy

35 044 0911 EN

Post traumatic scar, 1 treatment , 2 passes, 10 J/cm2, cover rate 15% and 4 shots on the same fractional spots

MicroSpot Superfractional Extension Set

By courtesy of Dr. Daniel, Cassuto, Milano, Italy

35 044 0911 EN

By courtesy of Dr. Feller-Heppt, University Hospital, Mannheim, Germany

MicroSpot Superfractional Extension Set

35 044 0911 EN

Single treatment, 20 J/cm2, 10 % cover rate, 3 shots on the same fractional spots, 1 and 7 days

MicroSpot Superfractional Extension Set

By courtesy of Dr. Feller-Heppt, University Hospital, Mannheim, Germany

35 044 0911 EN

Periorbital treatment only (forehead): single treatment, 20 J/cm2, 10 % cover rate, 3 shots on the same fractional spots, 1 and 7 days

MicroSpot Superfractional Extension Set

By courtesy of Dr. Feller-Heppt, University Hospital, Mannheim, Germany

35 044 0911 EN

BEFORE AFTER 3 treatments MCL 30 Dermablate 126 J/cm² , 13x13 mm fractional

By courtesy of Prof. Kabir Sardana, Delhi

MicroSpot Superfractional Extension Set

35 044 0911 EN

BEFORE AFTER 2 treatments MCL 30 Dermablate 126 J/cm² , 13x13 mm fractional 2 treatments, 2 Passes

MicroSpot Superfractional Extension Set

By courtesy of Prof. Kabir Sardana, Delhi

35 044 0911 EN

BEFORE AFTER 3 treatments MCL 30 Dermablate 162 J/cm² , 13x13 mm fractional 3 treatments, 3 Passes

MicroSpot Superfractional Extension Set

By courtesy of Prof. Kabir Sardana, Delhi

35 044 0911 EN

Dermal lesions 1. Khatri KA. Ablation of cutaneous lesions using an erbium:YAG laser. J Cosmet Laser Ther 2003; 5:1-4 2. Kaufmann R, Beier C. Erbium YAG laser therapy of skin lesions. Med Laser Appl 2001;16:252-263 3. Doi H, Ogawa Y, Hatoko M. Treatment of melanin-induced benign dermal lesions by an Erbium-YAG laser system. J Plast

Reprod Surg 2000; 0:90-95 4. Wollina U, Konrad H, Karamfilov T. Treatment of common warts and actinic keratosis by Er:YAG laser. J Cutan Laser Ther

2001;3:63-66 5. Beier C, Kaufmann R. Efficacy of erbium:YAG laser ablation in Darier disease and Hailey-Hailey disease. Arch Dermatol. 1999;

135(4):378-80 Aesthetic lesions (Skin Resurfacing) 1. Jasin ME. Achieving superior resurfacing results with the Erbium:YAG laser. Arch Facial Plast Surg 2002; 4:262-266 2. Perez MI, Bank DE. Facial skin resurfacing with the Erbium:YAG laser: new findings. Cosmetic Dermatology 1998;5:27-37 3. Khatri KA, Machado A, Magro C, Davenport S. Laser peel: facial rejuvenation with a superficial erbium:YAG laser treatment. J

Cutaneous Laser Ther 2000;2:119-123 4. Khatri KA, Ross V, Grevelink JM, Magro CM, Andersson RR. Comparison of erbium:YAG and carbon dioxide lasers in

resurfacing of facial rhytids. Arch Dermatol 1999;135(4):391-7

Bibliography Er:YAG-Laser

35 044 0911 EN

FDA USA

CE Europe

KFDA Korea

Thai-FDA Thailand

SFDA China

PPAD Taiwan

Made in Germany

MCL 30 Dermablate: cleared, approved and registered worldwide